Skip to main content

Table 3 Life-time risk (sum of pre-existing and incident cases) of developing genital warts in WOLVES cohorts (2010–2015). Statistical comparisons are shown for cohorts 1 versus 3, cohorts 2 versus 4, and participants analyzed in 2010 (cohorts 1 + 2) versus those analyzed in 2015 (cohorts 3 + 4)

From: Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis

Cohorta

N

Genital warts

Rate difference

(95% CI)

OR

No

Yes

 

1

659

628 (95.3%)

31 (4.7%)

0.0302

(0.0109, 0.052)P = 0.0018

2.8877 (1.426; 6.226) p = 0.0016

3

714

702(98.3%)

12(1.7%)

2

600

592(98.7%)

8(1.3%)

0.0106(−0.0042, 0.0255)P = 0.1598

4.9595 (0.660; 220.656) p = 0.1649

4

368

367(99.7%)

1(0.3%)

1 + 2

1259

1220(96.9%)

39(3.1%)

0.019(0.0068, 0.032) P = 0.0022

2.6287 (1.364; 5.395) p = 0.0018

3 + 4

1082

1069(98.8%)

13(1.2%)

  1. aCohort 1 born 1983/84 analyzed in 2009/10; cohort 2 born in 1988/89 analyzed in 2009/10; cohort 3 born 1988/89 analyzed in 2014/15; cohort 4 born 1993/94 analyzed in 2014/15